Compugen (CGEN) Other Gross PP&E Adjustments (2011 - 2025)
Compugen recorded quarterly Other Gross PP&E Adjustments of $4.4 million in Q4 2025, up 16.56% quarter-over-quarter from $3.8 million in Q4 2024, and up 16.56% year-over-year from $3.8 million in Q4 2024.
Compugen's Other Gross PP&E Adjustments history runs 9 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- In Q4 2025, Other Gross PP&E Adjustments rose 16.56% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (up 16.56% YoY), while the FY2025 annual figure was $4.4 million, up 16.56% from the prior year.
- Other Gross PP&E Adjustments came in at $4.4 million for Q4 2025 at Compugen, up from $3.8 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $5.9 million in Q4 2022 to a low of $3.8 million in Q4 2024.
- A 5-year average of $4.9 million and a median of $5.2 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments rose 20.86% in 2021 and declined 28.34% in 2024, its largest moves.
- Compugen's Other Gross PP&E Adjustments stood at $5.3 million in 2021, then climbed by 12.98% to $5.9 million in 2022, then decreased by 11.67% to $5.2 million in 2023, then retreated by 28.34% to $3.8 million in 2024, then gained by 16.56% to $4.4 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $4.4 million, $3.8 million, and $5.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 3.76 Mn |
| Dec 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | 5.94 Mn |
| Dec 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 5.25 Mn |
| Dec 31, 2021 | 5.25 Mn |
| Dec 31, 2020 | 4.35 Mn |
| Dec 31, 2020 | 4.35 Mn |
| Jun 30, 2019 | -784,000.00 |
| Jun 30, 2019 | -784,000.00 |
| Mar 31, 2019 | -4.76 Mn |
| Mar 31, 2019 | -4.76 Mn |
| Dec 31, 2013 | 10.03 Mn |
| Dec 31, 2013 | 10.03 Mn |
| Dec 31, 2012 | 9.70 Mn |
| Dec 31, 2012 | 9.70 Mn |
| Dec 31, 2011 | 8.65 Mn |
| Dec 31, 2011 | 8.65 Mn |